Open AccessS207: EFFICACY AND SAFETY OF A THIRD GENERATION CD20 CART (MB‐106) FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL)
Author(s) -
Shadman M.,
Yeung C.,
Redman M.,
Lee S. Y.,
Lee D. H.,
Ra S.,
Qian D.,
Ujjani C.,
Dezube B.,
Poh C.,
Warren E. H.,
Chapuis A.,
Green D.,
Cowan A.,
Cassaday R.,
Kiem H.P.,
Chow V.,
Gauthier J.,
Turtle C.,
Lynch R.,
Smith S.,
Gopal A.,
Maloney D.,
Till B.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843720.23634.a9
Subject(s) - medicine , fludarabine , cytokine release syndrome , follicular lymphoma , cyclophosphamide , lymphoma , cohort , oncology , immunology , gastroenterology , immunotherapy , chimeric antigen receptor , immune system , chemotherapy